Evidence map›Paper›PMID 30808984›Full record

ArticleScientific reports2019

Native mass spectrometry identifies an alternative DNA-binding pathway for BirA from Staphylococcus aureus.

Jiulia Satiaputra, Louise M Sternicki, Andrew J Hayes, Tara L Pukala, Grant W Booker, Keith E Shearwin, Steven W Polyak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jiulia SatiaputraSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Louise M SternickiSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Andrew J HayesSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID 0000-0001-8038-1656
Tara L PukalaSchool of Physical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID 0000-0001-7391-1436
Grant W BookerSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Keith E ShearwinSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Steven W PolyakSchool of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia. steven.polyak@adelaide.edu.au.ORCID 0000-0002-8458-5194
The University of Adelaide · AUHarry Perkins Institute of Medical Research · AUSA Health · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An adequate supply of biotin is vital for the survival and pathogenesis of Staphylococcus aureus. The key protein responsible for maintaining biotin homeostasis in bacteria is the biotin retention protein A (BirA, also known as biotin protein ligase). BirA is a bi-functional protein that serves both as a ligase to catalyse the biotinylation of important metabolic enzymes, as well as a transcriptional repressor that regulates biotin biosynthesis, biotin transport and fatty acid elongation. The mechanism of BirA regulated transcription has been extensively characterized in Escherichia coli, but less so in other bacteria. Biotin-induced homodimerization of E. coli BirA (EcBirA) is a necessary prerequisite for stable DNA binding and transcriptional repression. Here, we employ a combination of native mass spectrometry, in vivo gene expression assays, site-directed mutagenesis and electrophoretic mobility shift assays to elucidate the DNA binding pathway for S. aureus BirA (SaBirA). We identify a mechanism that differs from that of EcBirA, wherein SaBirA is competent to bind DNA as a monomer both in the presence and absence of biotin and/or MgATP, allowing homodimerization on the DNA. Bioinformatic analysis demonstrated the SaBirA sequence used here is highly conserved amongst other S. aureus strains, implying this DNA-binding mechanism is widely employed.

Indexed as

Amino Acid SequenceBacterial ProteinsBiotinCarbon-Nitrogen LigasesDimerizationDNAEscherichia coli ProteinsNanotechnologyProtein BindingProtein Structure, TertiaryRepressor ProteinsSpectrometry, Mass, Electrospray IonizationStaphylococcus aureusBacterial ProteinsBiotinbirA protein, E coliCarbon-Nitrogen LigasesDNAEscherichia coli ProteinsRepressor Proteins

Identifiers

PMID30808984
PMCPMC6391492
OpenAlexW2932335003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.